stars 1 stars 2 stars 3

KalVista Pharmaceuticals is a biopharmaceutical company developing oral medicines designed to empower people to enjoy everyday life beyond the challenge of their disease. We apply our expertise to discover, develop and commercialize oral protease inhibitor drugs based on deep expertise in the kallikrein-kinin system. Our commitment to rigorous science is driven by our determination to better address treatment needs for patients, beginning with sebetralstat, our first investigational product for hereditary angioedema (HAE), a rare genetic disease with debilitating attacks of tissue swelling that can be life threatening.

View Top Employees from KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. Questions

The KalVista Pharmaceuticals, Inc. annual revenue was $35.4 million in 2024.

Paul Audhya is the Chief Medical Officer of KalVista Pharmaceuticals, Inc..

111 people are employed at KalVista Pharmaceuticals, Inc..

KalVista Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

The NAICS codes for KalVista Pharmaceuticals, Inc. are [541, 32, 325, 54171, 54, 5417, 541714, 3254].

The SIC codes for KalVista Pharmaceuticals, Inc. are [873, 87].

Top KalVista Pharmaceuticals, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users